Physician profile
Vincent Francis Giacalone
NPI 1285637025
$73,632.81
in general payments reported to CMS, 2019-2025
40 companies · $39K in 2025
The $39K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $411 · 2021: $635 · 2022: $2,168 · 2023: $11K · 2024: $19K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Food and Beverage: $7,273 · Travel and Lodging: $6,065 · Consulting Fee: $2,000 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,416.00 |
| Food and Beverage | $7,273.39 |
| Travel and Lodging | $6,064.89 |
| Consulting Fee | $2,000.00 |
| Education | $218.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $50,124.61 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $15,678.66 | 2019-2025 | Puraply Antimicrobial, Puraply Wound Matrix, Apligraf |
| Orpyx Medical Technologies INC. | $2,000.00 | 2024 | |
| Smith+Nephew, INC. | $1,384.24 | 2020-2024 | Collagenase Santyl, Regranex, Grafix |
| Tactile Systems Technology INC | $660.52 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kerecis Limited | $527.43 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $479.73 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $397.49 | 2019-2025 | Augment Injectable, Citrefix, Infinity Adaptis |
| Treace Medical Concepts, INC. | $360.72 | 2021-2025 | |
| Urgo Medical North America, LLC | $225.97 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Djo, LLC | $218.00 | 2023 | Dr Comfort |
| Averitas Pharma INC. | $201.05 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $152.44 | 2022 | |
| Amgen INC. | $152.13 | 2024-2025 | Krystexxa |
| Abbott Laboratories | $139.60 | 2023 | Proclaim |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $135.05 | 2022 | |
| Endo USA, INC. | $79.64 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $73.11 | 2019-2023 | Jublia |
| Zimmer Biomet Holdings, INC. | $68.41 | 2019-2022 | |
| Boston Scientific Corporation | $63.13 | 2019 | |
| Abbvie INC. | $55.33 | 2022-2024 | |
| Vaporox, INC. | $47.48 | 2023 | Vht-200 Wound Treatment System |
| Orthofix Medical, INC. | $44.77 | 2024-2025 | Physio-Stim |
| Next Science LLC | $41.88 | 2023 | Blastx, Xperience, Surgx |
| Convatec INC. | $37.57 | 2023-2024 | |
| Fidia Pharma USA INC. | $35.00 | 2019 | |
| Medtronic, INC. | $34.72 | 2023 | Intellis Adaptivestim |
| Inari Medical, INC. | $34.11 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $31.29 | 2021 | |
| Resmed Corp | $29.86 | 2023 | |
| Zimvie INC. | $28.86 | 2022 | |
| Kci USA, INC. | $18.02 | 2021 | |
| Hydrofera LLC | $17.82 | 2024 | Hydrofera Blue |
| Hartmann USA, INC. | $16.58 | 2024 | Zetuvit Plus 10x10 P10 |
| Orpyx Medical Technologies US INC. | $16.41 | 2023 | Orpyx Si |
| Paragon 28, INC. | $11.73 | 2021 | |
| Cashflow Solutions, LLC | $9.45 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,591.80 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Giacalone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.